Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system

Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system

US Patent 10994028 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhancing agents for improved cell transfection and/or rAAV vector production2025
Enhancing agents for improved cell transfection and/or rAAV vector production2025
Scalable manufacturing platform for viral vector purification and viral vectors 2024
Scalable manufacturing platform for viral vector purification and viral vectors 2024
Large commercial scale lentiviral vector production system and vectors produced 2023
Large commercial scale lentiviral vector production system and vectors produced 2023
Column-based fully scalable rAAV manufacturing process2023
Column-based fully scalable rAAV manufacturing process2023
Methods for producing preparations of recombinant AAV virions substantially free2022
Methods for producing preparations of recombinant AAV virions substantially free2022
Humanized viral vectors and methods of use thereof2020
Rab Escort Protein potency assay2020